| scholarly article | Q13442814 |
| P2093 | author name string | A. Dumas | |
| T. Kaltsas | |||
| G. E. Krassas | |||
| N. Pontikides | |||
| P2860 | cites work | In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas | Q34538587 |
| The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors | Q34569188 | ||
| Octreotide and Graves' ophthalmopathy and pretibial myxoedema | Q35819873 | ||
| Octreotide and urinary glycosaminoglycan in Graves' disease | Q42764509 | ||
| High incidence of somatostatin receptors in human meningiomas: biochemical characterization | Q44574783 | ||
| Neuroanatomical localization for clinical SPECT perfusion brain imaging: a practical proportional grid method | Q48400029 | ||
| Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association | Q67020629 | ||
| Supervoltage orbital radiotherapy for Graves' ophthalmopathy | Q67249584 | ||
| Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy | Q68475631 | ||
| Somatostatin-receptor imaging in the localization of endocrine tumors | Q68480764 | ||
| Azathioprine in the treatment of thyroid-associated ophthalmopathy | Q68713064 | ||
| Short-term somatostatin infusion affects T lymphocyte responsiveness in humans | Q69368989 | ||
| Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin | Q69876221 | ||
| Somatostatin receptors in human endocrine tumors | Q70156764 | ||
| High Density of Somatostatin Receptors in Pituitary Tumors from Acromegalic Patients | Q72397947 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | scintigraphy | Q1130465 |
| eye disease | Q3041498 | ||
| Indium radioisotopes | Q74819973 | ||
| P304 | page(s) | 571-580 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease | |
| P478 | volume | 42 |
| Q53461322 | (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO). |
| Q51067652 | 99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy. |
| Q38617832 | Advances in the management of thyroid eye diseases: An overview |
| Q33955231 | An evidence-based approach to the treatment of Graves' ophthalmopathy |
| Q73289879 | Imaging Somatostatin Receptor Activity in Patients with Active Thyroid Eye Disease Using Tc-99m Depreotide |
| Q49353240 | Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs? |
| Q54334608 | Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy. |
| Q35785158 | Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy |
| Q44712930 | Octreotide scintigraphy for the diagnosis of active Graves' ophthalmopathy |
| Q73761107 | Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study |
| Q35785141 | Recent developments in Graves' ophthalmopathy imaging |
| Q79775301 | Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial |
| Q89977691 | Somatostatin Analogs in Clinical Practice: a Review |
| Q35785161 | Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy |
| Q37990407 | Somatostatin receptor SPECT. |
| Q92971116 | Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review |
| Q71141823 | Somatostatin-receptor scintigraphy in Graves' orbitopathy |
| Q42919451 | The Role of Intravenous Methylprednisolone Immunosuppression in the Management of Active Thyroid Eye Disease |
| Q81510853 | The cost of immunosuppressive therapies currently used in patients with thyroid eye disease |
| Q37239293 | The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease. |
| Q41085758 | The impact of octreotide in experimental proliferative vitreoretinopathy |
| Q41734163 | Treating severe Graves' ophthalmopathy |
| Q37060099 | Update on advanced imaging options for thyroid-associated orbitopathy |
| Q74775419 | [Endocrine orbitopathy 1998] |
| Q81797031 | [Grave's ophthalmopathy: therapeutic strategy. Review of 30 patients] |
Search more.